| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | YMAB | Common Stock | Purchase | $40.2K | +6.18K | +0.14% | $6.50 | 4.43M | Dec 7, 2023 | By WG Biotech ApS | F1, F4 |
| transaction | YMAB | Common Stock | Purchase | $129K | +18.5K | +0.42% | $6.99 | 4.45M | Dec 8, 2023 | By WG Biotech ApS | F2, F4 |
| transaction | YMAB | Common Stock | Purchase | $721K | +103K | +2.31% | $7.01 | 4.55M | Dec 11, 2023 | By WG Biotech ApS | F3, F4 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades each at price of $6.50. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | This transaction was executed in multiple trades at prices ranging from $6.90 to $7.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $6.86 to $7.15. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares. |